Skip to content

The safety and efficacy of catheter 3.0 system in diagnostic cerebral angiography: randomized controlled trial

The safety and efficacy of catheter 3.0 system in diagnostic cerebral angiography: randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0006644
Enrollment
200
Registered
2021-10-07
Start date
2021-09-13
Completion date
Unknown
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(diagnostic cerebral angiography) : Diagnostic cerebrovascular angiography was performed for patients with cerebral aneurysms, and the patients will be randomized into 4F catheter system group a

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who will undergo diagnostic cerebral angiography for intracranial aneurysm from September 13, 2021 (expected) to December 17, 2021 (expected) at our hospital.

Exclusion criteria

Exclusion criteria: A. When access to the femoral artery is not possible B. Patients under 18 years of age C. When fewer than 4 cerebrovascular vessels are expected to be examined (ex. follow-up study) D. Examination for Gamma Knife E. When the designated operator is unavailable F. When a procedure is required along with diagnostic cerebral angiography G. Previous history of diagnostic cerebral angiography

Design outcomes

Primary

MeasureTime frame
Procedural time;Complication rate

Secondary

MeasureTime frame
operator satisfaction;Image quality;Fluoroscopic time;Fluoroscopic dose;Number of catheters and guidewires used

Countries

Korea, Republic of

Contacts

Public ContactJongtae Yoon

Asan Medical Center

scolpion23@naver.com+82-2-2045-3712

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026